Enzolytics Inc. pays a Notavailable dividend of $156.25 which represents an annual dividend yield of N/A. See more information on Enzolytics Inc. dividends here

Q: How many shares outstanding does Enzolytics Inc. have?

Enzolytics Inc. has 3,941,644,000 shares outstanding.

463 Followers

ENZC Stock Chart & Stats

Advanced Chart >

Day’s Range― - ―

52-Week Range<$0.01 - $0.02

Previous CloseN/A

Volume3.47M

Average Volume (3M)10.43M

Market Cap

$3.74M

Enterprise ValueN/A

Total Cash (Recent Filing)$10.14K

Total Debt (Recent Filing)$284.51K

Price to Earnings (P/E)―

Beta-0.64

Next EarningsN/A

EPS EstimateN/A

Last Dividend Ex-Date

May 23, 2012

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding3,941,644,000

10 Day Avg. Volume3,601,563

30 Day Avg. Volume10,434,779

Standard Deviation1.49

R-Squared0.00104

Alpha0.28

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

―

Mutual Funds

<0.01% Other Institutional Investors

100.00% Public Companies and

Individual Investors

Detailed Ownership Overview >

ENZC FAQ

What was Enzolytics Inc.’s price range in the past 12 months?

Enzolytics Inc. lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.

What is Enzolytics Inc.’s market cap?

Enzolytics Inc.’s market cap is $3.74M.

When is Enzolytics Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Enzolytics Inc.’s earnings last quarter?

Currently, no data Available

Is Enzolytics Inc. overvalued?

According to Wall Street analysts Enzolytics Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Enzolytics Inc. pay dividends?

Enzolytics Inc. pays a Notavailable dividend of $156.25 which represents an annual dividend yield of N/A. See more information on Enzolytics Inc. dividends here

What is Enzolytics Inc.’s EPS estimate?

Enzolytics Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Enzolytics Inc. have?

Enzolytics Inc. has 3,941,644,000 shares outstanding.

What happened to Enzolytics Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Enzolytics Inc.?

Currently, no hedge funds are holding shares in ENZC

---

Company Description

Enzolytics Inc.

Enzolytics, Inc. is a development stage company, which engages in the research and development on the operations and treatment of HIV/Aids virus. It focuses on the commercialization of the license rights of the IPF for the treatment of Aids and Hepatitis C as well as potential other treatments for life threatening diseases. The company was founded on July 28, 2004 and is headquartered in Monrovia, CA.

---

Similar Stocks

CYDY

CytoDyn

―

BNGO

BioNano Genomics

―

INO

Inovio Pharmaceuticals

―

BRTX